Treatment outcome
| Response evaluation . | Concurrent, % (95% CI) . | Sequential, % (95% CI) . |
|---|---|---|
| Induction CR | 33 (20-46) | 15 (5-25) |
| Induction CR + PR | 90 (82-98) | 77 (66-89) |
| Consolidation PR to CR6-150 | 10 (2-18) | 22 (13-36) |
| Overall CR | 47 (33-61) | 28 (16-40) |
| Overall PR + CR | 90 (82-98) | 77 (66-89) |
| Response evaluation . | Concurrent, % (95% CI) . | Sequential, % (95% CI) . |
|---|---|---|
| Induction CR | 33 (20-46) | 15 (5-25) |
| Induction CR + PR | 90 (82-98) | 77 (66-89) |
| Consolidation PR to CR6-150 | 10 (2-18) | 22 (13-36) |
| Overall CR | 47 (33-61) | 28 (16-40) |
| Overall PR + CR | 90 (82-98) | 77 (66-89) |
CR indicates complete response; and PR, partial response.
Includes patients with PR after induction except for those with residual cytopenias, who are excluded.